These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 21030620

  • 1. Epigenetic drugs take on cancer.
    Kaiser J.
    Science; 2010 Oct 29; 330(6004):576-8. PubMed ID: 21030620
    [No Abstract] [Full Text] [Related]

  • 2. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M.
    J Cell Physiol; 2007 Aug 29; 212(2):330-44. PubMed ID: 17458893
    [Abstract] [Full Text] [Related]

  • 3. Novel approaches on epigenetics.
    Papait R, Monti E, Bonapace IM.
    Curr Opin Drug Discov Devel; 2009 Mar 29; 12(2):264-75. PubMed ID: 19333872
    [Abstract] [Full Text] [Related]

  • 4. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis.
    Vogiatzi P, Vindigni C, Roviello F, Renieri A, Giordano A.
    J Cell Physiol; 2007 May 29; 211(2):287-95. PubMed ID: 17238139
    [Abstract] [Full Text] [Related]

  • 5. Epigenetic therapies reach main street.
    Bates SE.
    Clin Cancer Res; 2009 Jun 15; 15(12):3917. PubMed ID: 19528089
    [No Abstract] [Full Text] [Related]

  • 6. Innovative approaches to the clinical development of DNA methylation inhibitors as epigenetic remodeling drugs.
    Murgo AJ.
    Semin Oncol; 2005 Oct 15; 32(5):458-64. PubMed ID: 16210086
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
    Bishton M, Kenealy M, Johnstone R, Rasheed W, Prince HM.
    Expert Rev Anticancer Ther; 2007 Oct 15; 7(10):1439-49. PubMed ID: 17944568
    [Abstract] [Full Text] [Related]

  • 8. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
    Mai A, Altucci L.
    Int J Biochem Cell Biol; 2009 Jan 15; 41(1):199-213. PubMed ID: 18790076
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic tools in potential anticancer therapy.
    Sebova K, Fridrichova I.
    Anticancer Drugs; 2010 Jul 15; 21(6):565-77. PubMed ID: 20436342
    [Abstract] [Full Text] [Related]

  • 10. Epigenetic alterations and cancer: new targets for therapy.
    Allen A.
    IDrugs; 2007 Oct 15; 10(10):709-12. PubMed ID: 17899489
    [Abstract] [Full Text] [Related]

  • 11. Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.
    Gjerstorff MF, Burns J, Ditzel HJ.
    Expert Opin Biol Ther; 2010 Jul 15; 10(7):1061-75. PubMed ID: 20420535
    [Abstract] [Full Text] [Related]

  • 12. The potential role of epigenetic therapy in multiple myeloma.
    Smith EM, Boyd K, Davies FE.
    Br J Haematol; 2010 Mar 15; 148(5):702-13. PubMed ID: 19912222
    [Abstract] [Full Text] [Related]

  • 13. DNA methyltransferase inhibitors for cancer therapy.
    Brueckner B, Kuck D, Lyko F.
    Cancer J; 2007 Mar 15; 13(1):17-22. PubMed ID: 17464242
    [Abstract] [Full Text] [Related]

  • 14. Targeting DNA methylation in cancer.
    Szyf M.
    Bull Cancer; 2006 Sep 15; 93(9):961-72. PubMed ID: 16980240
    [Abstract] [Full Text] [Related]

  • 15. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors.
    Schneider-Stock R, Ocker M.
    IDrugs; 2007 Aug 15; 10(8):557-61. PubMed ID: 17665331
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epigenetic cancer therapy makes headway.
    Mack GS.
    J Natl Cancer Inst; 2006 Oct 18; 98(20):1443-4. PubMed ID: 17047192
    [No Abstract] [Full Text] [Related]

  • 19. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.
    Lyko F, Brown R.
    J Natl Cancer Inst; 2005 Oct 19; 97(20):1498-506. PubMed ID: 16234563
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.